Currently, variability in APOE is the strongest known common genetic risk factor for late onset AD, in which the APOE ε4 allele increases disease risk and lowers the age at disease onset, whereas the APOE ε2 allele confers a protective effect against AD2–4. The gene discussed is APOE; the disease is Alzheimer disease.